In Canada/nursing study

Nursing Medication Card -Risperidone (Kor/Eng)

Shannon.p 2025. 5. 21. 07:00
반응형

Risperidone (리스페리돈)

  • 적응증: 조현병, 양극성 장애, 공격성 (치매 관련 행동 문제 포함)
  • 작용 기전: 도파민 D2 및 세로토닌 5-HT2 수용체 차단
  • 흡수와 대사: 경구 흡수 잘되며 간에서 CYP2D6에 의해 대사, 신장 배설
  • 부작용: 체중 증가, 졸음, 추체외로 증상, 고프로락틴혈증
  • 투여량: 1–6mg/일 (보통 1–2회 분할 투여)
  • 간호 고려사항: 추체외로 부작용 모니터링, 낙상 예방, 자살 위험성 평가

Risperidone (Risperdal)

  • 분류: 비정형 항정신병제
  • 적응증: 조현병, 양극성 장애, 자폐 관련 행동 문제
  • 부작용: 체중 증가, EPS(추체외로 증상), 졸림
  • 간호 포인트: 추체외로 증상 모니터링, 자살 위험 평가, 정기적인 혈당/지질 검사

 

Risperidone

Antipsychotics, mood stabilizers/benzisoxazoles 

Indications: schizophrenia조현병[증], short-term treatment of acute manic or mixed episodes associated w/ bipolar 1 disorder(PO only), maintenance treatment of bipolar 1 disorder(IM only), can be used w/ lithium or valproate, irritability associated w/ autistic disorder (PO only) 

Therapeutic effects: decreased symptoms of psychoses, bipolar mania, autism 

Absorption: 70% ac PO 

Distribution: unknown 

Metabolism&Excretion: by liver 

ADE: CNS; neuroleptic malignant syndrome, seizures, GI; constipation, diarrhea Metab; weight gain Dose: PO; 2-3 mg/day up at 24hr intervals by 1mg(range 1-5mg/day) 


Risperidone

Antipsychotics, mood stabilizers/benzisoxazoles

  • Indications: Schizophrenia 조현병[증] , bipolar disorder, irritability associated with autistic disorder.
  • Therapeutic Effects: Antipsychotic effects through dopamine D2 and serotonin 5-HT2 receptor antagonism.
  • Absorption: Rapidly absorbed orally; unaffected by food.
  • Distribution: Widely distributed; crosses the blood-brain barrier.
  • Metabolism & Excretion: Hepatic metabolism via CYP2D6; excreted in urine and feces.
  • Adverse Effects: Extrapyramidal symptoms, weight gain, hyperprolactinemia, sedation.
  • Dose: Initial: 1–2 mg/day; maintenance: 4–8 mg/day, adjusted based on response.
  • Considerations: Monitor for movement disorders; assess metabolic parameters regularly.DrugBankMedscape
반응형